This bill creates a new Commission on Black Women and Girls in New Jersey to address their specific needs through education, health, and policy recommendations. The commission will consist of eleven members, including several state officials and three public members appointed by the Governor to represent medical research and community organizations. Its primary function is to identify and suggest programs focused on issues like social-emotional learning, access to higher education, restorative justice in schools, and comprehensive sexual health education. While housed within the Department of Children and Families, the commission operates independently and has the authority to request information from various government entities to carry out its work.
This bill establishes a central registry in New Jersey to help emergency responders identify and assist residents with special needs during crises. Individuals or their legal guardians can voluntarily sign up to provide details such as their address, phone number, medical plans, and specific assistance requirements. Once registered, this information is shared with local police, fire departments, and emergency services to ensure they can prepare appropriate aid when responding to 9-1-1 calls or other emergencies. The legislation also mandates a public awareness campaign to encourage registration and restricts access to the data to only authorized emergency personnel and state officials.
This bill requires health benefits plans in New Jersey that use pharmacy benefits managers to allow any pharmacy meeting standard contract terms to join their network. The Commissioner of Banking and Insurance will define these terms as reasonable and relevant by reviewing existing contracts and ensuring reimbursement fees cover pharmacy ingredient and operational costs. The law applies to new or renewed contracts between health plans and pharmacy managers starting thirteen months after it is enacted.
This bill allows New Jersey healthcare providers to prescribe Schedule II controlled substances, such as certain pain medications, through telemedicine without requiring an in-person examination. It permits these prescriptions based on a remote provider-patient relationship, provided the provider has reviewed the patient's medical records and determined they can meet the standard of care remotely. The legislation also mandates that providers disclose their credentials, offer patients the option to see a physician specifically, and ensure proper follow-up care is arranged. By amending existing state laws, the bill expands access to specific controlled medications for patients using virtual healthcare services while maintaining regulatory oversight.
This bill requires healthcare platforms in New Jersey to advise and consult with consumers regarding the therapeutic values, hazards, and uses of drugs, biologicals, and devices they send. The law mandates that these platforms provide this information using electronic methods such as email, text messaging, or video calls. It directly affects online services that allow members to obtain discounts on medications or access telemedicine services. The legislation clarifies that these platforms must follow existing pharmacy practice standards when communicating with users about their prescriptions and medical devices.
This bill mandates that all students in grades six through twelve in New Jersey public and nonpublic schools undergo a specific physical examination that includes a cardiac component. To ensure this requirement is met, the physical must be performed by a licensed healthcare professional who has completed specialized training to recognize signs of heart disease and abnormalities. Schools are required to keep a signed form from the provider confirming that this specific training was completed before the student can participate in school activities. The law takes effect immediately and applies to the 2023-2024 school year, expanding upon existing rules that already require similar exams for student athletes.
This bill requires New Jersey's Department of Health to monitor and evaluate hospitals for compliance with federal rules on price transparency. The state agency will use methods such as reviewing complaints and auditing hospital websites to check if facilities are properly displaying their standard charges online. If a hospital is found noncompliant, the department can issue warnings, demand a corrective action plan, or impose civil monetary penalties that will be published on the department's website. Additionally, the department must publish an annual report detailing these compliance findings and any recommendations for the Governor and Legislature.
This bill creates the Targeted Midwifery Workforce Development Act to address racial disparities in maternal and infant health outcomes in New Jersey. It allocates $12 million to expand training and support for midwives, aiming to increase access to culturally competent care for Black communities who currently face higher risks of pregnancy-related death and infant mortality. The legislation directly affects healthcare providers, educational institutions, and state agencies involved in workforce development and maternal health services. By investing in midwifery education and addressing systemic inequities, the bill seeks to improve birth outcomes and reduce the gap between Black and white residents in the state.
This New Jersey Assembly resolution urges the federal government to pass a bill that would remove waiting periods for disability benefits and Medicare for people with young-onset Alzheimer's diagnosed before age 65. The proposed federal law aims to eliminate the current 29-month delay in Medicaid coverage, ensuring these individuals receive medical support immediately upon diagnosis. By addressing bureaucratic delays, the legislation seeks to provide timely access to care for approximately 200,000 Americans affected by the disease and their families.
This bill creates the Kidney Disease Study Commission within New Jersey's Department of Health to investigate kidney disease research. The nine-member commission will include state officials and six public members appointed by legislative and executive leaders to oversee studies on disease causes, treatment patterns, and transplant rates, with a specific focus on minority and underserved populations. The commission will hold public hearings, utilize state staff for support, and submit annual reports to the Governor and Legislature detailing its findings and recommendations.
